Connect with us

Latest News

Research animals get new lease on life

Published

on

Get breaking news alerts and special reports. The news and stories that matter, delivered weekday mornings.

Ringo the beagle loves all the things every dog would: Running in the yard, rides in the car and the frequent snack.

“He’s just so happy to sit right in your lappy,” his owner, Amy Bleich, an engineer in Edgewater, Maryland, said.

You’d never know that Ringo, now five years old, had lived the entire first two years of his life inside a small cage at a nearby medical laboratory. When he was first adopted by the Bleich family in 2015, he was nervous around people and other dogs, and thrown off by the feel of grass beneath his paws and cool gusts of wind under his floppy ears.

Dogs like Ringo rarely seem to get a happy ending. A majority of dogs that have been subjects of medical research and experimentation are euthanized and destroyed when the laboratory they live in has completed its tests, according animal welfare groups.

Image: Therapy Dog Ringo
Therapy Dog Ringo with Zev Bleich, age 6.Courtesy Amy Bleich

But, thanks to a growing number of states that have passed legislation cracking down on the practice by mandating that research laboratories must first attempt to adopt out healthy animals that have survived the research tests, thousands more dogs and cats may find homes.

Since 2014, Minnesota, Connecticut, Nevada, California, Illinois and New York have all enacted so-called “Beagle Freedom” laws, named for the dog breed that is most commonly tested on due its particularly docile nature. Just last month, Maryland Republican Gov. Larry Hogan signed his state’s bill into law, and on Tuesday, Delaware’s General Assembly passed a similar measure (it had already passed the state Senate), sending it to Gov. John Carney, a Democrat, for his signature.

“Every animal, who can, should be afforded the opportunity at life in a loving home after their time in the laboratory. That’s the very least we should do for them,” Kathleen Conlee, vice president of animal research issues for the Humane Society of the United States, told NBC News.

Nearly 61,000 dogs and nearly 19,000 cats lived in medical and scientific research laboratories in 2016, the most recent year for which data is available, according to the Animal and Plant Health Inspection Service division of the U.S. Department of Agriculture. (In total, nearly 821,000 animals were used for medical and scientific testing in 2016, according to the agency’s records.)

Animal welfare advocates don’t know exactly how many of those dogs and cats are euthanized after research, but most estimate that a vast majority are put down.

Under the U.S. Animal Welfare Act, medical and scientific laboratories must disclose the number and type of animals on which they’re conducting testing and periodically allow in federal inspectors, who make sure the facilities comply with minimal requirements that pertain to the living conditions of the animals in the labs.

But they aren’t required under the law to report what they do with the animals after the research has concluded, which advocates say is the primary reason states have gotten involved.

Image: Beagle rescue
A former medical animal test subject, a beagle, hesitates to leave a pet carrier during a First Steps of Freedom Event held by the Rescue + Freedom Project.Courtesy Rescue + Freedom Project

Another five legislatures — in Indiana, Iowa, Massachusetts, Rhode Island, and New Jersey — are currently debating similar bills.

“These are compassionate, common sense bills that don’t have a real down side,” said Matt Rossell, the director of advocacy, programs campaign and public policy at the Rescue + Freedom Project, a Los Angeles-based animal rights nonprofit focused on securing freedom for creatures that have lived in laboratory settings.

“These animals have lived in a very stark environment that does not at all resemble what life looks like for dogs and cats in homes. Small cages, no potty training, they haven’t even had opportunities to be outside,” he said. “No fresh air. They haven’t even ever touched the grass.”

Skeptics, many of whom are actually animal welfare advocates, say that the bills are not enforceable, because they don’t require institutions to report what they have done with their animals and don’t offer any punitive measures for institutions that don’t comply with the requirements that they prioritize adoption over euthanasia.

Image: Beagle rescue
Volunteers hold a beagle’s ear to reveal the tattoo ID from the beagle’s time as a medical animal test subject.Courtesy Rescue + Freedom Project

But experts maintain that the laws are working, pointing to public attention and shame as a forceful deterrent.

“I actually think they’re quite effective. These science institutions are large and sophisticated and hyper-aware of public relations and don’t want to be shamed when animal welfare groups expose them for killing all of these animals,” said David Favre, a law professor at Michigan State University’s College of Law, whose expertise is animal law.

“And it’s not going to hurt (the institutions) to take the high ground. These (laws) don’t curb their research, they just help the dogs,” said Favre. “And besides,” he added, “you don’t really want to go and arrest scientist anyway.”

Advocates, and pet owners, say the benefits of the bills don’t just apply to animals.

Jeremy Bernard, a southern California author who worked as former President Barack Obama’s social secretary, says his life has only been enriched by the two beagles — both former inhabitants of medical labs — he’s adopted in recent years.

Image: Jeremy Bernard and Mason
Jeremy Bernard and MasonCourtesy of Jeremy Bernard

Mason, adopted in December, came to him a “nervous puppy” who got especially anxious before his breakfast, Bernard said.

“I got the sense he must have been fed and tested in the AM,” Bernard said.

But now, just six months later, “he loves playing with other dogs and people … and his breakfast.”

“He’s so affectionate,” Bernard said. “I watch him when it’s windy and he looks up at the sky and I don’t think he has any idea what wind is. But it makes him really happy. And it makes me happy watching him.”

“I don’t think he has any idea what his life used to be like,” he added.

Source link

Latest News

Uganda presidential election: Incumbent Yoweri Museveni declared winner | World News

Published

on

Yoweri Museveni has been declared the winner of the Uganda presidential election with 58.64% of the total votes, according to the country’s electoral commission.

The incumbent will now serve a sixth term as president of the east African nation following some of the worst pre-election violence since the 76-year-old took office in 1986.

His man opposition, singer Bobi Wine, has alleged vote rigging throughout the process and had strong support in urban centres where frustration with unemployment and corruption remains high. He won 3.48 million votes, or 34.8% of the total, according to the commission.

Bobi Wine's trademark red beret has become a symbol of opposition to longtime President Yoweri Museveni.
Image:
Opposition candidate Bobi Wine was assaulted and arrested several times during the election campaign

Mr Wine and other opposition candidates were often harassed, and more than 50 people were killed when security forces halted riots in November after he was arrested.

Although Mr Museveni holds on to power, at least 15 of his cabinet ministers including the vice president were voted out, with many losing to candidate’s from Mr Wine’s party, according to local media.

Mr Wine, real name Kyagulanyi Ssentamu, claimed victory on Friday and said he had video evidence of vote-rigging and insisting “every legal option is on the table” to challenge the election results.

He was beaten up and arrested several times during the election campaign but was never convicted of any charge. He later wore a flak jacket and said he feared for his life.

On Saturday, Mr Wine said his home in the capital Kampala had been surrounded by soldiers and the military was now allowing him to leave.

The army’s deputy spokesman, Deo Akiiki, told Reuters security officers were assessing threats to Mr Wine if left his home.

Monitoring of the elections has been hit by the arrest of independent observers and the denial of accreditation for members of the UN observer mission.

Tibor Nagy, the top US diplomat for Africa, tweeted on Saturday that “Uganda’s electoral process has been fundamentally flawed”, adding that the “US response hinges on what the Ugandan government does now”.

Source link

Continue Reading

Latest News

COVID-19: India begins vaccine roll-out and aims to administer 300 million jabs by August | World News

Published

on

India has began its ambitious project of vaccinating its 1.3 billion citizens – as it aims to administer 300 million jabs by August.

Prime Minister Narendra Modi launched the voluntary vaccination programme at 3,006 locations across the country this morning.

About 300,000 health workers will be vaccinated today and the numbers will increase as more capacity is enhanced every week.

In the first phase, vaccines will be given to 30 million health and frontline workers for free.

In its second phase 270 million citizens over the age of 50 and those under 50 with other health problems will be vaccinated.

There is an air of relief and optimism at the Rajiv Gandhi Super Speciality hospital as the first beneficiaries line up for the jab.

There is also relief and celebration by health workers at the Lok Nayak Jai Prakash (LNJP) Hospital in Delhi.

Biji Tony was the first nurse to be vaccinated at Lok Nayak Jai Prakash Hospital in Delhi
Image:
Biji Tony was the first nurse to be vaccinated at the Lok Nayak Jai Prakash Hospital in Delhi

Staff nurse Biji Tony, the first to be vaccinated there, told Sky News: “I am so relieved. It has been a very difficult year, working day and night.

“We’ve stayed away from family and loved ones. We are human as well. Now all this ends. We are not afraid anymore after we get the second dose.”

Dr Suresh Kumar, the medical superintendent at the LNJP hospital, told Sky News: “Today is a historic day and like a festival, we are feeling as if we have won a super world cup.

“But it has come with a lot of struggle. We have lost doctors and staff to the virus. But now we are ready to win the COVID war.”

The two vaccines, the Oxford-AstraZeneca’s “Covishield” and Bharat Biotech’s “Covaxin”, were approved for emergency use by the Central Drugs and Standards Committee (CDSCO) on 3 January.

Millions of doses of Covishield, manufactured by the Serum Institute of India at its Pune plant, and Covaxin, produced by Bharat Biotech in Hyderabad, were transported under security to various cities across the nation.

The approval of the latter has raised concerns amongst scientists and epidemiologists as third phase trails are still ongoing and its efficacy has not yet been published.

Prime minister Modi said: “The DCGI (Drug Controller General of India) gave approval after they were satisfied with the data of the two vaccines. So stay away from rumours.”

Professor KS Reddy, president of the Public Health Foundation Of India (PHFI) – a non- profit organisation and a watchdog of public health – said: “Ideally at the best of circumstances one should see the phase three trials completed and efficacy data fully evaluated and out in the public domain through scientific publications as well as other scrutiny.

“However in this pandemic situation it was felt that given the large number of persons in India that need to be immunised the potential escalation of the epidemic due to mutants. I think the policy makers have taken the decision, I too wish the trial could have been completed earlier.

“But as far as the safety is concerned it has been adequately proven for Covaxin. But anyone who has doubts of the vaccine need not take it even if it is offered, they can decline it.”

Healthcare workers are being prioritised in the vaccine roll-out
Image:
Healthcare workers are being prioritised in the vaccine roll-out

Indian Health Ministry spokesperson Rajesh Bhushan said: “There is no option for recipients to choose which vaccine they want to be inoculated with.”

Preparations for these dry runs took place in more than 700 districts across the country with mock transportation and dummy injections by more than 150,000 health staff.

The country has 29,000 cold-chain points, 240 walk-in coolers, 70 walk-in freezers, 45,000 ice-lined refrigerators, 41,000 deep freezers and 300 solar refrigerators for storage.

Immunising a country that is almost 2,000 miles north to south and the same east to west with over a billion people will be a herculean task.

Reaching remote and rural areas where most of India lives and where the infrastructure is wanting will be a challenge.

Added to this is a second jab required to complete the cycle.

And then there are the many summer months where temperatures soar to 40C (104 F) or more in most parts of the country.

It has been a tragic winter for the Sharma household

Deviram Sharma, 65, died within four days of being admitted to a hospital with the virus.

His son Avneesh is donning a PPE suit to perform the last rites at Nigambodh Ghat – the largest Hindu crematorium.

Subscribe to the Daily podcast on Apple Podcasts, Google Podcasts, Spotify, Spreaker

Families have no time for mourning as farewells are hurried and from afar due to restrictions.

Traditional last rites are rushed under the overbearing shadow of the virus, the bereavement a mere formality.

Avneesh told Sky News: “It has jolted our family, it has shaken our roots, even I had to go on medication and am still feeling low myself.

“I hope and pray that this virus is removed through the use of vaccination and others don’t have to suffer what our family has gone through.”

With more than 10.5 million cases, India is the second worst affected country after the United States.

Almost 152,000 deaths have been reported so far and the need for a vaccine has never been as critical as now.

Source link

Continue Reading

Latest News

COVID-19: Indonesia vaccine rollout bucks trend by targeting younger generations | UK News

Published

on

With shaking hands, broadcast live to the nation, a doctor administered Indonesia’s first COVID-19 vaccination.

The recipient was President Joko Widodo, a man who hopes to get 181.5 million Indonesians vaccinated this year.

It’s a huge challenge, almost three times the population of the UK and so far one of the largest rollouts in the world.

But the nation’s vaccination drive, which started this week using CoronaVac, a jab from Chinese manufacturer Sinovac Biotech, bucks the current trend by injecting under-60s first.

You can find out more about Indonesia’s COVID-19 vaccine drive on the Sky News Daily Podcast

Subscribe to the Daily podcast on Apple Podcasts, Google Podcasts, Spotify, Spreaker

Dr Siti Nadia Tarmizi, COVID-19 vaccination spokesperson for Indonesia’s Ministry of Health, told Sky News: “18 to 59 is the age group that gets most infected by COVID-19 and mostly without symptoms. We know between 18 and 59 is a more productive age group, so if we are targeting this age group first, we will protect them from COVID-19, which means they can, of course, go to work.

“And then secondly, by protecting this age group, we will cut the transmission.”

Indonesia has recorded more than 25,400 deaths and 880,000 infections making it Southeast Asia’s worst outbreak.

Testing levels are low, so experts warn the actual infection rate could be much higher.

Starting with frontline workers, under-60s will be inoculated first not only because the government hopes protecting workers will boost the economy, but it’s also waiting for more safety data about how CoronaVac impacts the elderly.

Medical official with vaccine dose
Image:
A medical official prepares to administer a vaccine dose

In Indonesia’s capital city, Jakarta, where people who refuse the jab will face fines, some are wary.

“If I had the option to refuse the vaccine, I would say no,” said Guntur Dwi Adiputra, “For sure I will be afraid to have it because I don’t know the side-effects.”

“I understand the perspective economic reasons, however, I feel that those people, productive people, they could wait because they’re not the ones risking their lives first, the elderly are the ones at stake right now,” added local resident Angel Utomo.

Officials on steps
Image:
Officials on steps

Indonesia is the fourth most populous country in the world and the pandemic has left many struggling financially.

Mohammed Santri’s catering business previously sold more than 200 meals a day, but since the coronavirus outbreak it’s dropped to just 10.

The family now runs it alone after all the paid staff had to be let go.

“I hope that the vaccination process will be implemented as soon as possible because when people are healthy and they can go back to work then I will receive orders again,” Mr Santri said.

CoronaVac is easier for many developing countries to store than some of the other vaccines as it can be kept in the fridge.

Unlike the Pfizer and Moderna mRNA vaccines which have been given the green light in the UK, the Sinovac-made jab uses inactivated coronavirus.

Monk speaks to official
Image:
A monk speaks to an official

Patients are injected with killed viral particles to expose the body’s immune system to the virus and teach it to make antibodies.

Interim data in Indonesia put the efficacy at 65.3% but extended results from Brazil found it to be just 50.4% effective, barely over the 50% needed for regulatory approval.

Researchers at Sao Paulo’s Butantan Institute who conducted the trials previously stressed it was 78% effective against mild to severe cases.

Sinovac Biotech is Indonesia’s biggest vaccine supplier, and while the country is buying other brands, officials explained the Chinese could deliver fastest.

“I think the main reason why Sinovac is being used in Indonesia is that they committed to deliver this vaccine at the end of December 2020, while the others were still in the negotiation process,” Dr Nadia said.

“We plan to have 181.5 million of the population vaccinated, which means we need like 426 million doses of vaccine which is a really huge number and it may not be able to be fulfilled by only having one vaccine type or vaccine factory.”

Military official receives COVID-19 vaccine.
Image:
A military official receives his COVID-19 vaccine

While many countries in the West are focusing on European and American-made vaccines, in Asia, nations including Indonesia, the Philippines and Thailand are all starting with Sinovac.

Dicky Budiman, an epidemiologist at Australia’s Griffith University, said China has deliberately positioned itself to fill a gap in the market and supply developing countries which would otherwise face a long wait.

“Vaccine diplomacy has become one of the tools for big countries to improve and increase their power in the region. China will use this as a diplomatic power, that’s for sure,” he said.

But with more than 270 million people to protect and surging cases, it’s a power game Indonesia’s willing to play, with leaders hoping this will be a turning point in the fight against the pandemic

Source link

Continue Reading

Trending